Company Name: Fatima Fertilizer Company Limited
Ticker: FATIMA
Reporting period: Three months and six months ended June 30, 2026. The analysis uses the unaudited consolidated interim financial statements as the primary reporting basis because they capture Fatima Fertilizer Company Limited together with its wholly owned subsidiaries. The standalone half-year statements were subject to a limited-scope review by the statutory auditor; the consolidated interim statements are presented as unaudited.
Verdict
Fatima Fertilizer’s second quarter was materially stronger than the first-half headline alone suggests. Consolidated Q2 sales rose 31.0% year on year, gross profit increased 52.5%, operating profit rose 64.9% and profit after tax more than doubled. The core signal is margin expansion: Q2 gross margin moved to 38.19% from 32.80% and operating margin to 27.91% from 22.17%. That happened despite a roughly two-and-a-half-month shutdown at the Sheikhupura plant, which pulled first-half combined fertilizer production 7.1% below the comparable period. The company offset weaker production with record first-half sales volumes, stronger market demand and a favorable sales mix. Official H1 2026 report.
The result is not completely clean, however. Q2 other income rose sharply and the half-year note shows meaningful realized and unrealized investment gains, so the doubling in quarterly PAT should not be treated as entirely recurring. Cash generation improved strongly, but the group simultaneously stepped up capital expenditure and deployed substantial funds into long-term advances and strategic investments, including PIA Equity Limited. The next cycle therefore has two separate questions: whether the manufacturing margin gains can persist, and whether the much larger capital-allocation commitments convert into acceptable economic returns without creating financing pressure. Official H1 2026 report.
AlphaGen model readings
Alpha QoQ Score: 89.18
TTM Performance Score: 89.17
3Y Business Perf Score: 71.3
Sector Leadership Score: 81.0389
These four readings are AlphaGen model outputs, not company-reported figures. They are presented separately from the public financial statements and do not constitute investment advice.
Results at a glance
- Q2 consolidated sales were Rs83.76 billion versus Rs63.94 billion, up 31.0%. Gross profit rose to Rs31.99 billion from Rs20.97 billion and operating profit increased to Rs23.38 billion from Rs14.17 billion. Official consolidated profit-and-loss statement.
- Q2 profit before tax was Rs26.96 billion, up 93.2%, while PAT reached Rs17.20 billion versus Rs8.56 billion. Quarterly EPS rose to Rs8.19 from Rs4.08. Official consolidated profit-and-loss statement.
- For H1 2026, consolidated revenue increased 12.7% to Rs130.61 billion, gross profit 20.5% to Rs50.52 billion, operating profit 21.4% to Rs34.66 billion, and PAT 20.7% to Rs20.44 billion. H1 EPS was Rs9.73 versus Rs8.06. Official H1 2026 report.
- The group sold 1.210 million tonnes of fertilizer in H1, including 1.201 million tonnes of own-manufactured product, versus 1.163 million and 1.144 million tonnes respectively a year earlier. Management described the own-manufactured volume as its highest-ever first-half sales volume. Directors’ report.
- H1 net cash generated from operating activities increased to Rs14.06 billion from Rs5.06 billion, even after Rs23.63 billion of taxes and Rs4.21 billion of finance cost were paid. Capital expenditure on property, plant and equipment increased to Rs11.63 billion from Rs3.32 billion. Official cash-flow statement.
What improved
The clearest improvement was manufacturing economics. Q2 cost of sales rose about 20.5%, materially slower than the 31.0% increase in revenue. That widened quarterly gross margin by about 5.4 percentage points to 38.19%. Distribution and administrative costs also grew more slowly than gross profit, which allowed operating margin to expand by roughly 5.7 percentage points to 27.91%. This matters because operating profit excludes the volatile investment-related income that affected the bottom line. The quarter therefore showed a genuine improvement before non-operating items rather than a profit increase driven only by financial income. Official consolidated statements.
The half-year operating pattern was also constructive. H1 gross margin rose to about 38.68% from 36.18%, while operating margin improved to roughly 26.54% from 24.63%. Management said cost of sales increased 8.3% because of higher volumes and inflationary pressure, but gross profit still rose faster than revenue. Finance cost declined 9.5% year on year to Rs3.54 billion, providing another recurring benefit below operating profit. The effective tax rate remained broadly similar to the prior period, so the H1 PAT improvement was not primarily the result of a lower tax burden. Directors’ report and financial statements.
Volume growth overcame a production setback
The operational story is more impressive because production itself was weaker. The Sheikhupura plant remained shut for almost two and a half months after gas supply was suspended amid regional supply disruption. As a result, combined own-manufactured fertilizer production fell 7.1% to 1.320 million tonnes from 1.421 million tonnes. Urea production dropped to 458,000 tonnes from 557,000 tonnes, while Nitrophos production rose modestly and CAN production was slightly lower. Management used the outage for in-house modifications and overhauls, but the shutdown still reduced available output. Directors’ report.
Sales nevertheless moved the other way. Own-manufactured sales increased about 5% to 1.201 million tonnes. Nitrophos sales rose to 383,000 tonnes from 357,000 tonnes, CAN to 403,000 from 397,000 and urea to 415,000 from 390,000. DAP sales fell to 9,000 tonnes from 19,000 tonnes. The mix therefore shifted toward the company’s core nitrogen and Nitrophos products while purchased DAP volumes remained small. The company said it maintained a 32% market share in an expanding local fertilizer market. Official H1 2026 report.
The sector backdrop helps explain why the company could grow sales despite the production outage. Fatima’s directors reported total industry fertilizer offtake of 3.823 million tonnes in H1, up 6.3%, with urea offtake up 6.9%, DAP up 6.2% and Nitrophos up 9.4%. NFDC data reported by Mettis show that June itself was more mixed: urea offtake rose 1.6% year on year while DAP fell sharply, and domestic fertilizer prices increased month on month. This supports a reading in which H1 demand was stronger overall but phosphate affordability became increasingly restrictive late in the period. Company market review. NFDC June context.
Recurring earnings versus non-recurring support
The recurring part of the recovery is visible in sales volumes, gross margin, operating margin and lower H1 finance cost. Those lines are tied to fertilizer demand, product economics and cost absorption. The less recurring part sits in other income. Q2 other income increased to Rs7.27 billion from Rs3.51 billion, which helped quarterly PBT grow much faster than operating profit. For the full six months, however, other income actually fell 18.5% to Rs4.67 billion because the timing of investment income moved substantially between quarters. Official consolidated statements.
The H1 other-income note makes the distinction clearer. It includes Rs1.61 billion of unrealized gains on investments measured at fair value through profit or loss, Rs1.18 billion of realized investment gains and Rs700 million of dividend income. These are legitimate reported earnings, but they are more variable than fertilizer manufacturing margins and should not automatically be annualized. For judging the next result, operating profit and core product margins are therefore cleaner indicators of business momentum than the Q2 PAT growth rate alone. Official other-income note.
Cash flow improved, but capital deployment accelerated
Cash generated from operations rose 78% to Rs42.21 billion, and net operating cash flow increased 178% to Rs14.06 billion from Rs5.06 billion. The improvement is significant because taxes paid also rose sharply to Rs23.63 billion from Rs14.50 billion. Trade receivables fell by roughly half from the December year-end to Rs16.20 billion, while cash and bank balances more than doubled to Rs6.24 billion. These movements indicate stronger collections and operating conversion, although the period-end cash figure should not be read in isolation because the group also carried substantial running finance. Official cash-flow and balance-sheet statements.
Investment spending also stepped up. Property, plant and equipment additions were Rs11.63 billion, more than three times the comparable period, and capital work in progress rose to Rs19.47 billion from Rs11.24 billion at December. Inventory increased 20.7% to Rs77.51 billion, including higher raw materials and finished Nitrophos, urea and CAN stocks. That inventory build is not automatically negative given the gas-supply uncertainty and seasonal fertilizer market, but it ties up working capital and creates exposure to future selling prices and demand. Official balance sheet and notes.
The largest change outside the core fertilizer cycle was long-term advances and deposits, which rose to Rs38.97 billion from Rs12.08 billion. The notes disclose Rs22.93 billion of share-deposit money advanced to PIA Equity Limited, alongside a separate initial subscription for PIA Equity shares, as part of the consortium’s investment following the first financial closure of the PIA privatization transaction. This is a major capital-allocation development. It did not drive the fertilizer operating margin improvement, but it will matter increasingly to group liquidity, financing needs and future consolidated returns. Official investment and related-party notes.
The financing picture is mixed but not as weak as the rise in short-term borrowing alone suggests. Short-term secured finance increased 53% to Rs49.67 billion, while non-current long-term finance rose to Rs7.12 billion. Yet the current portion of long-term liabilities fell from Rs37.85 billion to Rs2.40 billion after large repayments. Combining those major secured financing balances gives about Rs59.2 billion at June versus roughly Rs72.9 billion at December, a decline of about 19%. Even so, cash and cash equivalents were negative Rs31.94 billion because running finance and running musharakah exceeded cash balances. Official balance sheet and cash-flow statement.
What weakened / needs attention
- Production reliability remains the most direct operating risk. The Sheikhupura shutdown demonstrated how exposed nitrogen fertilizer output can be to gas availability. Management said plants on the SNGPL network had resumed operations from mid-August, but it explicitly called for continuous gas supply ahead of Rabi. Management outlook.
- Phosphate affordability is deteriorating. Management reported higher sulphur, ammonia and phosphoric-acid costs and warned that high local DAP prices could push farmers toward more affordable nitrogen products. That substitution may support urea demand, but it can also weaken higher-value phosphate volumes and reshape product mix. Fertilizer market review.
- Investment income is volatile. Q2 other income was unusually strong, while H1 other income declined year on year. Fair-value gains, realized investment gains and dividends can move sharply between quarters and should be separated from manufacturing profitability. Official other-income note.
- Capital allocation has become more complex. The group is simultaneously funding fertilizer capex, larger working-capital inventories and strategic investments including PIA-linked commitments. Strong operating cash flow provides capacity, but the economic returns and funding structure of these deployments deserve separate monitoring. Official cash-flow and investment notes.
Dividend and corporate developments
The half-year statements record the Rs2.50-per-share final dividend for FY2025 as a transaction with owners, reducing consolidated reserves by Rs5.25 billion. Cash dividends paid during H1 were Rs3.16 billion because payment timing differs from the accounting recognition of the declared dividend. The June report does not present a new interim cash dividend for H1 2026. Official statement of changes in equity and cash flows.
The Board authorized the H1 2026 financial statements on August 19, 2026, and the quarterly report was transmitted to PSX on August 28. The group-level reporting basis is especially important this year because the standalone comparative figures were restated after the Multan plant was carved out into wholly owned Pakarab Fertilizers Limited effective January 1, 2025. For analytical consistency, this article therefore uses the consolidated current and comparative numbers rather than mixing them with the restated standalone series. Fatima Group announcement. PSX announcements.
What to monitor next
- Gas continuity and plant utilization: whether Sheikhupura and other SNGPL-linked fertilizer plants operate continuously through the Rabi build-up, and whether production recovers from the 7.1% H1 decline.
- Q3/Q4 margin durability: Q2 gross and operating margins improved sharply. The next result should show whether those gains persist when production normalizes and fertilizer pricing adjusts.
- Urea versus phosphate demand: monitor farmer affordability, DAP/Nitrophos pricing and whether substitution toward nitrogen products becomes visible in company volumes and national offtake.
- Inventory and cash conversion: the Rs77.51 billion stock balance needs to be viewed alongside sales volumes, receivable collection, operating cash flow and short-term financing.
- Capital deployment: track fertilizer capex and capital work in progress separately from PIA Equity, REIT and other related-party investments so that core operating returns are not obscured by group-level capital allocation.
- Other income: realized and unrealized investment gains were meaningful in H1 and particularly supportive in Q2. Recurring earnings quality will be clearer if operating profit continues to grow without needing similar non-operating gains.
Bottom line
Fatima Fertilizer’s June 2026 quarter showed a meaningful acceleration in the core business. Stronger sales volumes and favorable operating leverage lifted margins even with one major plant constrained by gas supply. The H1 result confirms that this was not simply an accounting rebound: revenue, gross profit, operating profit, operating cash flow and equity all improved, while finance cost declined. The company also retained a 32% market share and achieved a record first-half own-manufactured sales volume. Official H1 2026 report.
The result nevertheless marks a transition from a relatively straightforward fertilizer earnings story into a broader capital-allocation story. Investment gains boosted Q2 below the operating line, inventory rose, capex accelerated and substantial funds were committed to PIA Equity and other long-term investments. The next result should therefore be judged on two levels: first, whether fertilizer volumes and margins remain strong as gas supply and farm economics evolve; and second, whether the group can fund its expanding strategic commitments without weakening liquidity or diluting the quality of cash returns from the core fertilizer business.